Search Results - "WENANDY, Lynn"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    The Immunogenicity of the hTERT540-548 Peptide in Cancer by Wenandy, Lynn, Sørensen, Rikke Baek, Sengeløv, Lisa, Svane, Inge Marie, thor Straten, Per, Andersen, Mads Hald

    Published in Clinical cancer research (01-01-2008)
    “…Human telomerase reverse transcriptase (hTERT), the catalytic subunit of telomerase, is an attractive target antigen for cancer immunotherapy due to its…”
    Get full text
    Journal Article
  2. 2

    Identification of a new hTERT-derived HLA-A0201 restricted, naturally processed CTL epitope by Thorn, Mette, Wang, Mingjun, Kløverpris, Henrik, Schmidt, Esben G W, Fomsgaard, Anders, Wenandy, Lynn, Berntsen, Annika, Brunak, Søren, Buus, Søren, Claesson, Mogens H

    Published in Cancer Immunology, Immunotherapy (01-11-2007)
    “…By the use of a neural network capable of performing quantitative predictions of peptides binding to HLA-A*0201 molecules, we identified a number of nonamer…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease by Dong, Shen, Maiella, Sylvie, Xhaard, Aliénor, Pang, Yuanyu, Wenandy, Lynn, Larghero, Jérome, Becavin, Christophe, Benecke, Arndt, Bianchi, Elisabetta, Socié, Gérard, Rogge, Lars

    Published in Blood (05-09-2013)
    “…Understanding the heterogeneity of human CD4+FOXP3+ regulatory T cells (Tregs) and their potential for lineage reprogramming is of critical importance for…”
    Get full text
    Journal Article
  5. 5

    Therapeutic Dendritic Cell Vaccination of Patients With Metastatic Renal Cell Carcinoma : A Clinical Phase 1/2 trial by BERNTSEN, Annika, TREPIAKAS, Redas, SVANE, Inge Marie, WENANDY, Lynn, GEERTSEN, Poul F, THOR STRATEN, Per, ANDERSEN, Mads H, PEDERSEN, Anders E, CLAESSON, Mogens H, LORENTZEN, Torben, JOHANSEN, Julia S

    Published in Journal of immunotherapy (1997) (01-10-2008)
    “…Therapeutic dendritic cell (DC) vaccination against cancer is a strategy aimed at activating the immune system to recognize and destroy tumor cells. In this…”
    Get full text
    Journal Article
  6. 6
  7. 7

    RhoC a new target for therapeutic vaccination against metastatic cancer by Wenandy, Lynn, Sørensen, Rikke Bæk, Svane, Inge Marie, thor Straten, Per, Andersen, Mads Hald

    Published in Cancer Immunology, Immunotherapy (01-12-2008)
    “…Most cancer deaths are due to the development of metastases. Increased expression of RhoC is linked to enhanced metastatic potential in multiple cancers…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11